Let's start with Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the treatment of endocrine disorders and other metabolic diseases. The company's arsenal includes novel drugs that are first-in-class or best-in-class and are developed as...

Bitcoin's chances of reaching the $40,000 mark are becoming a top priority for cryptocurrency speculators as they enter the finish line of a year in which the largest digital asset more than doubled in value....

European stocks rose and U.S. Treasuries traded little changed ahead of comments from Federal Reserve Chairman Jerome Powell that could provide a clue on how interest rates will evolve. The Stoxx 600 index was up...

Private cryptocurrencies with no intrinsic value are likely to disappear in the long term, predicted Singapore's central bank governor Ravi Menon at a discussion today organized by the Hong Kong Monetary Authority and the Bank...

Finland's battered stock market could offer investors a benefit next year as a potential global economic recovery could lift cyclical stocks that dominate the index and NATO membership eases risks related to Russia, according to...